State of ArtThe growing dilemma of legalized cannabis and heart transplantation
Section snippets
Disparities in clinical practice
There are wide variations in clinical practice among transplant centers regarding cannabis. The American Society of Transplantation surveyed members and noted variations in transplant candidacy policy (28% rejected all patients, 52% varied by organ), cannabis screening (55% screened all candidates, 20% screened based on organ), and concern for route of administration (11% allowed edibles only).6 An electronic survey of adult solid organ transplant centers in the United States (U.S.) reflecting
Recreational versus medical cannabis
Should transplant centers make a distinction between recreational versus medicinal cannabis usage? Medical conditions for medicinal usage vary despite evidence only supporting a few conditions such as chronic pain, chemotherapy induced nausea and emesis, and spasticity due to multiple sclerosis.9 In the U.S., chronic pain remains the most common reason for medicinal usage, accounting for 68% of license holders.10 Unfortunately, this symptom is common and subjective. Among the remainder U.S.
Addiction and cannabis use disorder
Cannabis addiction is often compared to other drug abuse which adversely affect transplant outcome (Table 1). Cannabis addiction occurs with long-term use, increases in prevalence among users starting during adolescence,11 and is associated with underlying psychiatric disorders and history of polysubstance abuse.12,13 In one study of 61 transplant candidates referred for abuse and dependence, 42% had depression, 27% had anxiety, and 31% had polysubstance abuse.12 Tolerance as well as
Cannabis active and inactive ingredients
The main molecules responsible for the various effects of cannabis are cannabinoids. More than 100 exist9 including Δ9-tetrahydrocannabinol (THC) which is responsible for the psychoactive effects, cannabidiol (CBD) which has anti-inflammatory and anti-proliferative effects, and other minor cannabinoid molecules such as cannabinol.24 Cannabinoids are naturally produced by plants and humans and synthetically produced such as prescription medications like dronabinol or illicit drugs like “Spice.”25
Transplant drug interactions
THC and CBD have been reported to modulate the effects of many CYP enzymes and drug transporters in in-vitro and in-vivo studies.25 CBD may also mediate interactions with enzymes in the UGT system.25 These potential drug interactions may interfere with immunosuppressant therapy and other drugs (Table 3). Calcineurin inhibitors, like tacrolimus, make up the backbone of chronic immunosuppression therapy. CBD products can raise tacrolimus levels by inhibiting the CYP3A4 and P-glycoprotein, a
Transplant outcomes
Data on cannabis and transplantation is sparse and limited by small sample size, retrospective analyses, and limited outcome data. This literature review combines transplant data from different organs and includes case reports.
Potential cardiovascular complications
Although the cannabis literature for transplantation is sparse, there are cardiovascular adverse effects concerning for potential transplant complications. These concerns are described below.
Future considerations
Cannabis usage remains controversial because it is widely accessible, legalized for medicinal and/or recreational purposes in several states and countries, and adverse events may be attributable to a lack of regulatory standards for the cultivation of cannabis products, leading to impurities and infections. To address cannabis in future transplant guidelines we should consider route of administration, frequency of usage, and dependency. Inhaled cannabis is more deleterious than edible cannabis
Disclosures
None.
Dr. Hsich is supported by the National Heart, Lung and Blood Institute of the National Institute of Health under Award Number R01HL141892 to study disparities in survival among heart transplant candidates and recipients. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
References (63)
- et al.
The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update
J Heart Lung Transplant
(2016) - et al.
Canadian cardiovascular society/Canadian cardiac transplant network position statement on heart transplantation: patient eligibility, selection, and post-transplantation care
Can J Cardiol
(2020) - et al.
Marijuana use and candidacy for heart transplantation
J Heart Lung Transplant
(2019) - et al.
Marijuana use in patients with cardiovascular disease: JACC review topic of the week
J Am Coll Cardiol
(2020) - et al.
Cannabis abuse and dependence in kidney transplant candidates
J Psychosom Res
(2019) - et al.
Marijuana use in potential liver transplant candidates
Am J Transplant
(2009) - et al.
Changing landscape of cannabis: novel products, formulations, and methods of administration
Curr Opin Psychol
(2019) - et al.
A marijuana-drug interaction primer: precipitants, pharmacology, and pharmacokinetics
Pharmacol Ther
(2019) - et al.
A new method of cannabis ingestion: the dangers of dabs?
Addict Behav
(2014) - et al.
Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus
Am J Transplant
(2019)
Chronic pain treatment with cannabidiol in kidney transplant patients in uruguay
Transplant Proc
Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety
Life Sci
Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity
Drug Metab Pharmacokinet
Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient
Chest
Ventricular tachycardia due to marijuana use in a heart transplant patient
Rev Esp Cardiol
[Cannabis-induced cerebral and myocardial infarction in a young woman]
Rev Neurol (Paris)
Coronary no-flow and ventricular tachycardia associated with habitual marijuana use
Ann Emerg Med
Cannabis as a precipitant of cardiovascular emergencies
Int J Cardiol
Acute cardiovascular fatalities following cannabis use
Forensic Sci Int
An exploratory prospective study of marijuana use and mortality following acute myocardial infarction
Am Heart J
Heavy cannabis users at elevated risk of stroke: evidence from a general population survey
Aust N Z J Public Health
Recreational marijuana use and acute ischemic stroke: a population-based analysis of hospitalized patients in the United States
J Neurol Sci
Cannabis-related stroke: case series and review of literature
J Stroke Cerebrovasc Dis
Is thromboangiitis obliterans presentation influenced by cannabis addiction?
Ann Vasc Surg
Panizzon RG: cannabis arteritis
J Am Acad Dermatol
Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the American Heart Association
Circulation
Marijuana use in transplantation: a call for clarity
Clin Transplant
The clinical conundrum of cannabis: current practices and recommendations for transplant clinicians: an opinion of the immunology/transplantation PRN of the American College of Clinical Pharmacy
Transplantation
Marijuana and listing for heart transplant: a survey of transplant providers
Circ Heart Fail
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
Qualifying conditions of medical cannabis license holders in the United States
Health Aff (Millwood)
Cited by (7)
Cannabidiol's impact on drug-metabolization
2023, European Journal of Internal MedicineThe Year in Cardiothoracic Transplant Anesthesia: Selected Highlights From 2021 Part II: Cardiac Transplantation
2023, Journal of Cardiothoracic and Vascular AnesthesiaPreparation for lung transplantation
2023, Revue des Maladies RespiratoiresCannabis Use and Heart Transplantation: Disparities and Opportunities to Improve Outcomes
2022, Circulation: Heart FailureClinical Considerations for Cannabis Use and Cardiovascular Health
2022, Medical Cannabis and Cannabinoids